Obesity - Pipeline Review, H1 2015

1
Obesity - Pipeline Review, H1 2015
2
Report Description
Summary Global Markets Directs, Obesity -
Pipeline Review, H1 2015, provides an overview
of the Obesitys therapeutic pipeline. This
report provides comprehensive information on the
therapeutic development for Obesity, complete
with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type, along with latest updates, and
featured news and press releases. It also reviews
key players involved in the therapeutic
development for Obesity and special features on
late-stage and discontinued projects. Global
Markets Directs report features investigational
drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is
built using data and information sourced from
Global Markets Directs proprietary databases,
Company/University websites, SEC filings,
investor presentations and featured press
releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Get
More About This Report At http//www.bigmarketres
earch.com/obesity-pipeline-review-h1-2015-market
3
Report Description
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Enquire About This Report At
http//www.bigmarketresearch.com/report-enquiry/18
2244
4
Report Description
Scope - The report provides a snapshot of the
global therapeutic landscape of Obesity - The
report reviews key pipeline products under drug
profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities - The report reviews key players
involved in the therapeutics development for
Obesity and enlists all their major and minor
projects - The report summarizes all the dormant
and discontinued pipeline projects - A review of
the Obesity products under development by
companies and universities/research institutes
based on information derived from company and
industry-specific sources - Pipeline products
coverage based on various stages of development
ranging from pre-registration till discovery and
undisclosed stages - A detailed assessment of
monotherapy and combination therapy pipeline
projects - Coverage of the Obesity pipeline on
the basis of target, MoA, route of administration
and molecule type - Latest news and deals
relating related to pipeline products
5
Report Description
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage - Develop strategic initiatives by
understanding the focus areas of leading
companies - Identify and understand important and
diverse types of therapeutics under development
for Obesity - Plan mergers and acquisitions
effectively by identifying key players of the
most promising pipeline - Devise corrective
measures for pipeline projects by understanding
Obesity pipeline depth and focus of Indication
therapeutics - Develop and design in-licensing
and out-licensing strategies by identifying
prospective partners with the most attractive
projects to enhance and expand business potential
and scope - Modify the therapeutic portfolio by
identifying discontinued projects and
understanding the factors that drove them from
pipeline
6
Table Of Contents
Chapter one Introduction Chapter two Obesity
Overview Chapter three Therapeutics
Development Chapter four Obesity -
Therapeutics under Development by
Companies Chapter five Obesity - Therapeutics
under Investigation by Universities/Institutes Cha
pter six Obesity - Pipeline Products
Glance Chapter seven Obesity - Products under
Development by Companies Chapter Eight Obesity
- Products under Investigation by
Universities/Institutes Chapter Nine Obesity -
Companies Involved in Therapeutics
Development Get Complete TOC at
http//www.bigmarketresearch.com/obesity-pipeline-
review-h1-2015-market
7
Table Of Contents
Chapter Ten Obesity - Therapeutics Assessment
Chapter Eleven Drug Profiles Chapter Twelve
Obesity - Recent Pipeline Updates Chapter
Thirteen Obesity - Dormant Projects Chapter
Fourteen Obesity - Discontinued Products
8
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/obesity-pipeline-
review-h1-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
sales_at_bigmarketresearch.com